Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancer.
Atkins
C D
CD
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004961:Estramustine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005485:Flutamide; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D004961:Estramustine; D005047:Etoposide; D005485:Flutamide